Product Information
LABETALOL HCL 300 MG TABLET is a generic product labeled by Major Pharmaceuticals, priced at $0.2086 per EA under NDC 00904745361. Its NADAC has been published 70 times since Feb 26, 2025.
Strength
300 mg/1
Manufacturer
Major PharmaceuticalsNDC
00904745361
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LABETALOL HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA209603On Market Since
10/8/2024
Pharmacological Classes
Price Statistics
The NADAC for LABETALOL HCL 300 MG TABLET has been published 70 times since Feb 26, 2025, and over the history we have for it it has risen 6.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2086 per EA |
|---|---|
| All-time high | $0.2117 (Sep 10, 2025) |
| All-time low | $0.1954 (Feb 26, 2025) |
| 52-week high | $0.2117 |
| 52-week low | $0.1998 |
| Median price | $0.2045 |
| Average price | $0.2048 |
| Largest weekly change | +3.9% (Mar 19, 2025) |
| Weeks tracked | 70 |
| Tracking since | Feb 26, 2025 |
Generic Alternatives
The matcher finds 11 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 2% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of LABETALOL HCL 300 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LABETALOL HCL 300 MG TABLET, manufactured by Major Pharmaceuticals, is $0.2086 per EA (NDC 00904745361), effective Jun 24, 2026.
How has the price of LABETALOL HCL 300 MG TABLET changed over time?
Over the history we have for it, the NADAC for LABETALOL HCL 300 MG TABLET has risen 6.8%. It has been tracked across 70 weekly CMS publications since Feb 26, 2025.
What are the highest and lowest recorded NADAC prices for LABETALOL HCL 300 MG TABLET?
Since Feb 26, 2025, the NADAC for LABETALOL HCL 300 MG TABLET has ranged from a low of $0.1954 (Feb 26, 2025) to a high of $0.2117 (Sep 10, 2025), with a median of $0.2045 per EA.
Are there cheaper alternatives to LABETALOL HCL 300 MG TABLET?
Yes. 11 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, LABETALOL HCL 300 MG TABLET, is $0.2041 per EA — about 2% below LABETALOL HCL 300 MG TABLET.
Who manufactures LABETALOL HCL 300 MG TABLET?
LABETALOL HCL 300 MG TABLET (NDC 00904745361) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.
Related Drugs
Same classification